Diclofenac and Paracetamol Combination Therapy

Introduction to Combination Therapy

The American Society of Clinical Oncology and the European Society for Medical Oncology recommend combining diclofenac with paracetamol for enhanced pain control, as they have complementary mechanisms of action 1, 2
The combination of diclofenac and paracetamol provides additive analgesia through different mechanisms, with paracetamol working primarily through central COX inhibition and descending serotonergic pathways, and diclofenac providing peripheral anti-inflammatory effects through COX-1 and COX-2 inhibition 1, 2

Multiple international guidelines, including those from the European Society for Medical Oncology, explicitly recommend combining WHO Step I analgesics, such as paracetamol, with NSAIDs, such as diclofenac, for enhanced pain control 1, 2
The European Society for Medical Oncology guidelines state that strong opioids may be combined with the ongoing use of a level I agent, establishing the precedent that non-opioid analgesics from different classes can be used together 1

Paracetamol can be dosed at 650-1000 mg every 4-6 hours, with a maximum daily dose of 4000 mg, and diclofenac can be dosed at 25-75 mg every 8-12 hours, with a maximum daily dose of 150 mg 1, 2, 3
For patients without risk factors, paracetamol can be dosed at 1000 mg every 6 hours, with a maximum daily dose of 4000 mg, and diclofenac can be dosed at 50 mg every 8-12 hours, with a maximum daily dose of 100-150 mg 1, 2, 3

Patients with any degree of renal insufficiency should avoid diclofenac or use it with extreme caution, as it inhibits prostaglandin synthesis critical for maintaining renal perfusion in compromised kidneys, according to the National Comprehensive Cancer Network 3, 4
Patients with congestive heart failure must not receive diclofenac, as the European Society of Cardiology gives NSAIDs a Class III recommendation with Level B evidence in heart failure patients, stating they cause sodium and water retention, worsening renal function, and worsening heart failure 3, 4
History of peptic ulcer disease or gastrointestinal bleeding is an absolute contraindication to diclofenac, as diclofenac has been identified as possessing potentially higher cardiovascular risk compared to other traditional NSAIDs, according to the Journal of the American Geriatrics Society 5, 3

If diclofenac must be used in patients with GI risk factors, such as age ≥60 years, male gender, concurrent corticosteroid use, anticoagulant therapy, or untreated H. pylori, a proton pump inhibitor should be co-prescribed, as recommended by the 2004 guidelines from Alimentary Pharmacology and Therapeutics 5, 6, 3
Patients receiving aspirin for cardioprotection face heightened GI bleeding risk when NSAIDs are added, and either a COX-2 inhibitor or PPI gastroprotection should be used, according to the Journal of the American Geriatrics Society and Alimentary Pharmacology and Therapeutics 5, 7, 6

Chronic paracetamol use should be limited to ≤3000-4000 mg/day due to hepatotoxicity concerns, as recommended by the European Society for Medical Oncology and the Annals of the Rheumatic Diseases 1, 2, 8, 3
Paracetamol efficacy in musculoskeletal pain is modest and possibly inferior to NSAIDs, according to the Journal of the American Geriatrics Society and the Annals of the Rheumatic Diseases 7, 8

Baseline assessment before starting combination therapy should include blood pressure, BUN, creatinine, liver function tests, CBC, and stool occult blood, as recommended by Praxis Medical Insights 3, 4
Ongoing monitoring requirements include weekly monitoring for the first 3 weeks, then every 3 months, for high-risk patients, such as the elderly, those with borderline renal function, heart failure, or cirrhosis, according to Praxis Medical Insights 3, 4

The combination of diclofenac with ACE inhibitors, ARBs, or diuretics creates compounded nephrotoxicity risk and should be avoided, as stated by the FDA label and Praxis Medical Insights 4
Diclofenac reduces the natriuretic effect of loop and thiazide diuretics, potentially causing diuretic resistance and fluid retention, according to Praxis Medical Insights 4
Combining diclofenac with other NSAIDs or aspirin at anti-inflammatory doses increases GI toxicity without improving efficacy, and should be avoided, as recommended by Praxis Medical Insights and Alimentary Pharmacology and Therapeutics 3, 6